P.A.W. Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

P.A.W. Capital’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,333	Closed	-$295K	–	26
2022 Q4	$295K	Sell	8,333 -9,667	-54%	-$1.16M	0.81%	23
2022 Q3	$4.07M	Hold	18,000	–	–	6.09%	2
2022 Q2	$3.4M	Hold	18,000	–	–	4.94%	5
2022 Q1	$4.48M	Buy	18,000 +1,333	+8%	+$211K	4.68%	5
2021 Q4	$2.6M	Buy	16,667 +3,334	+25%	+$645K	2.38%	14
2021 Q3	$2.67M	Hold	13,333	–	–	2.38%	12
2021 Q2	$3.41M	Buy	13,333 +666	+5%	+$166K	2.86%	11
2021 Q1	$3.36M	Sell	12,667 -666	-5%	-$210K	2.96%	11
2020 Q4	$4.92M	Buy	13,333 +1,333	+11%	+$382K	4.34%	6
2020 Q3	$2.93M	Buy	12,000 +2,000	+20%	+$622K	3.19%	13
2020 Q2	$2.88M	Sell	10,000 -2,000	-17%	-$590K	3.26%	11
2020 Q1	$2.45M	Buy	12,000 +7,200	+150%	+$2.29M	3.3%	11
2019 Q4	$2.15M	Sell	4,800 -1,867	-28%	-$663K	2.29%	19
2019 Q3	$2.05M	Hold	6,667	–	–	2.56%	14
2019 Q2	$2.12M	Buy	6,667 +334	+5%	+$116K	2.29%	17
2019 Q1	$2.66M	Sell	6,333 -1,000	-14%	-$401K	2.63%	11
2018 Q4	$2.23M	Buy	7,333 +6,166	+528%	+$1.99M	2.8%	12
2018 Q3	$420K	Sell	1,167 -1,833	-61%	-$627K	0.45%	60
2018 Q2	$1.1M	Sell	3,000 -1,500	-33%	-$534K	1.11%	29
2018 Q1	$1.33M	Buy	4,500 +1,167	+35%	+$345K	1.6%	23
2017 Q4	$1.4M	Buy	3,333 +666	+25%	+$238K	1.75%	21
2017 Q3	$880K	Buy	+2,667	New	+$727K	0.92%	48

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

P.A.W. Capital's EIGR Position: Q1 2023 in Review

P.A.W. Capital sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2023, closing a stake of 8,333 shares — an estimated $295K sold.

P.A.W. Capital first reported a position in EIGR in Q3 2017 and held it in 22 quarters. The position peaked at $4.92M in Q4 2020. 71 funds tracked by Wall St. Rank hold EIGR as of Q1 2023.

P.A.W. Capital reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
P.A.W. Capital sold 8,333 Eiger BioPharmaceuticals, Inc. shares in Q1 2023, an estimated $295K.
P.A.W. Capital first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2017 and held it in 22 quarters.
P.A.W. Capital's Eiger BioPharmaceuticals, Inc. position peaked at $4.92M in Q4 2020.
71 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2023.

Based on P.A.W. Capital's 13F filing for Q1 2023, filed 1 May 2023.